About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
PTC THERAPEUTICS, INC. (PTCT): Insider Trades and Fund Holdings
In the past 12 months, PTC THERAPEUTICS, INC. insiders reported no open-market purchases and 28 sales worth $22.1M; 28 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 14, 2026Insider saleDirector Michael Schmertzler sold $149,036 under a 10b5-1 plan
- Oct 9, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $12,338 under a 10b5-1 plan
- Oct 9, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $12,339 around Oct 9, 2026
- Oct 7, 2026Insider saleDirector Michael Schmertzler sold $158,480 under a 10b5-1 plan
- Oct 7, 2026Planned saleSection Six Partners, L.P. (affiliate of director) filed notice to sell about $643,500 around Oct 7, 2026
- Oct 6, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $27,910 under a 10b5-1 plan
- Oct 6, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $27,908 around Oct 6, 2026
- Oct 5, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $104,881 under a 10b5-1 plan
- Oct 5, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $104,883 around Oct 5, 2026
- Sep 30, 2026Insider saleDirector Steele Glenn Jr Md Phd sold $781,920 under a 10b5-1 plan
- Sep 30, 2026Planned saleSTEELE GLENN JR MD PHD (director) filed notice to sell about $781,920 around Sep 30, 2026
- Sep 17, 2026Insider saleDirector Michael Schmertzler sold $678,533 under a 10b5-1 plan
- Sep 16, 2026Insider saleDirector Michael Schmertzler sold $671,195 under a 10b5-1 plan
- Sep 10, 2026Insider saleDirector Michael Schmertzler sold $673,400 under a 10b5-1 plan
- Sep 9, 2026Insider saleDirector Michael Schmertzler sold $678,403 under a 10b5-1 plan
- Sep 9, 2026Planned saleSection Six Partners, L.P. (affiliate of director) filed notice to sell about $2.7 million around Sep 9, 2026
- Aug 28, 2026NewsCompany reported: Signed a material agreement
- Aug 27, 2026Insider saleDirector Michael Schmertzler sold $894,784 under a 10b5-1 plan
- Aug 26, 2026Insider saleDirector Michael Schmertzler sold $911,726 under a 10b5-1 plan
- Aug 25, 2026Planned saleSection Six Partners, L.P. (affiliate of director) filed notice to sell about $3.6 million around Aug 19, 2026
- Aug 20, 2026Insider saleDirector Michael Schmertzler sold $888,858 under a 10b5-1 plan
- Aug 19, 2026Insider saleDirector Michael Schmertzler sold $916,554 under a 10b5-1 plan
- Aug 19, 2026Planned saleMichael Schmertzler (director) filed notice to sell about $3.6 million around Aug 19, 2026
- Aug 17, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $204,127 under a 10b5-1 plan
- Aug 17, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $201,692 around Aug 17, 2026
- Aug 4, 2026Insider saleCEO Matthew B. Klein sold $705,722 under a 10b5-1 plan (5 days after: quarterly or annual results)
- Aug 4, 2026Planned saleKlein Matthew B. (officer, director) filed notice to sell about $705,754 around Aug 4, 2026
- Jul 30, 2026NewsCompany reported: Quarterly or annual results; Executive or director change
- Jul 14, 2026Insider saleCFO Pierre Gravier sold $280,743 under a 10b5-1 plan
- Jul 9, 2026Insider saleDirector Mary L. Smith sold $1.4 million under a 10b5-1 plan
- Jul 9, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $222,376 under a 10b5-1 plan
- Jul 7, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $2.2 million under a 10b5-1 plan
- Jul 6, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $1.9 million under a 10b5-1 plan
- Jul 6, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $432,118 under a 10b5-1 plan
- Jun 30, 2026FundRenaissance Technologies added 36% in Q2 2026 (13F filed Aug 13, 2026)
- Jun 26, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $693,152 under a 10b5-1 plan
- Jun 25, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $1.8 million under a 10b5-1 plan
- Jun 24, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $452,607 under a 10b5-1 plan
- Jun 22, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $1.9 million under a 10b5-1 plan
- Jun 17, 2026Insider saleCAO Christine Marie Utter sold $1.5 million under a 10b5-1 plan
Showing the latest 40 of 41 events.
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 16 | Michael SchmertzlerDirector | ▼ SELL10b5-1 | $149K |
| Oct 13 | Mark Elliott BouldingGeneral Counsel | ▼ SELL10b5-1 | $12K |
| Oct 9 | Michael SchmertzlerDirector | ▼ SELL10b5-1 | $158K |
| Oct 7 | Mark Elliott BouldingGeneral Counsel | ▼ SELL10b5-1 | $105K |
| Oct 7 | Mark Elliott BouldingGeneral Counsel | ▼ SELL10b5-1 | $28K |
| Oct 2 | Steele Glenn Jr Md PhdDirector | ▼ SELL10b5-1 | $782K |
| Sep 18 | Michael SchmertzlerDirector | ▼ SELL10b5-1 | $679K |
| Sep 18 | Michael SchmertzlerDirector | ▼ SELL10b5-1 | $671K |
| Sep 11 | Michael SchmertzlerDirector | ▼ SELL10b5-1 | $678K |
| Sep 11 | Michael SchmertzlerDirector | ▼ SELL10b5-1 | $673K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Michael Schmertzler | Director | 0 | $0 | 10 | $6.62M |
| Mark Elliott Boulding | General Counsel | 0 | $0 | 6 | $1.60M |
| Steele Glenn Jr Md Phd | Director | 0 | $0 | 1 | $782K |
| Matthew B. Klein | CEO | 0 | $0 | 1 | $706K |
| Pierre Gravier | CFO | 0 | $0 | 1 | $281K |
| Mary L. Smith | Director | 0 | $0 | 1 | $1.43M |
| Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 0 | $0 | 7 | $9.18M |
| Christine Marie Utter | CAO | 0 | $0 | 1 | $1.49M |
A All 28 insider trades reported on time. How it is graded
Tracked funds that report PTCT
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 723,500 | $59.0M | ▲ +35.7% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →